Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancer.
Ajona D, Pajares MJ, Corrales L, Perez-Gracia JL, Agorreta J, Lozano MD, Torre W, Massion PP, de-Torres JP, Jantus-Lewintre E, Camps C, Zulueta JJ, Montuenga LM, Pio R.
Ajona D, et al. Among authors: agorreta j.
J Natl Cancer Inst. 2013 Sep 18;105(18):1385-93. doi: 10.1093/jnci/djt205. Epub 2013 Aug 12.
J Natl Cancer Inst. 2013.
PMID: 23940286
Free PMC article.